Fidelity Select Pharmaceuticals Portfolio (FPHAX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
23.67
+0.36 (1.54%)
May 19, 2025, 8:04 PM EDT
FPHAX Holdings List
As of Mar 31, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | LLY | Eli Lilly and Company | 24.89% |
2 | NVO | Novo Nordisk A/S | 12.25% |
3 | AZN | AstraZeneca PLC | 10.29% |
4 | GSK | GSK plc | 5.63% |
5 | GILD | Gilead Sciences, Inc. | 5.44% |
6 | MRK | Merck & Co., Inc. | 5.29% |
7 | EBR: UCB | UCB SA | 4.87% |
8 | RPRX | Royalty Pharma plc | 2.98% |
9 | n/a | Fidelity Cash Central Fund | 2.90% |
10 | ELAN | Elanco Animal Health Incorporated | 2.31% |
11 | LEGN | Legend Biotech Corporation | 2.17% |
12 | SWX: ROG | Roche Holding AG | 2.04% |
13 | ZTS | Zoetis Inc. | 2.02% |
14 | RNA | Avidity Biosciences, Inc. | 1.94% |
15 | JAZZ | Jazz Pharmaceuticals plc | 1.12% |
16 | PTCT | PTC Therapeutics, Inc. | 0.94% |
17 | XENE | Xenon Pharmaceuticals Inc. | 0.80% |
18 | LUNG | Pulmonx Corporation | 0.74% |
19 | ETR: MRK | Merck KGaA | 0.72% |
20 | BNTX | BioNTech SE | 0.72% |
21 | n/a | Metsera 180day Lu Line 7/30/25 | 0.64% |
22 | RCUS | Arcus Biosciences, Inc. | 0.60% |
23 | IRON | Disc Medicine, Inc. | 0.54% |
24 | MRNA | Moderna, Inc. | 0.53% |
25 | EBR: TUB | Financière de Tubize SA | 0.53% |
26 | AXSM | Axsome Therapeutics, Inc. | 0.53% |
27 | n/a | Cash | 0.49% |
28 | ASND | Ascendis Pharma A/S | 0.47% |
29 | EBR: IBAB | Ion Beam Applications SA | 0.41% |
30 | MRUS | Merus N.V. | 0.37% |
31 | HRMY | Harmony Biosciences Holdings, Inc. | 0.36% |
32 | QURE | uniQure N.V. | 0.36% |
33 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.35% |
34 | BEAM | Beam Therapeutics Inc. | 0.34% |
35 | NTLA | Intellia Therapeutics, Inc. | 0.31% |
36 | DYN | Dyne Therapeutics, Inc. | 0.29% |
37 | SMMT | Summit Therapeutics Inc. | 0.28% |
38 | EBR: NYXH | Nyxoah SA | 0.28% |
39 | OCUL | Ocular Therapeutix, Inc. | 0.27% |
40 | SRPT | Sarepta Therapeutics, Inc. | 0.26% |
41 | AVBP | ArriVent BioPharma, Inc. | 0.20% |
42 | EYPT | EyePoint Pharmaceuticals, Inc. | 0.20% |
43 | n/a | Agomab Therapeutic Ser D Pc Pp | 0.17% |
44 | n/a | Agomab Therapeutic Ser C Pc Pp | 0.17% |
45 | n/a | Paragon Biosc Emalex C Pc Pp | 0.17% |
46 | EWTX | Edgewise Therapeutics, Inc. | 0.15% |
47 | VIR | Vir Biotechnology, Inc. | 0.15% |
48 | VKTX | Viking Therapeutics, Inc. | 0.13% |
49 | n/a | Castle Creek Bios Sr D-1 Pc Pp | 0.12% |
50 | n/a | Evozyne Cpik 6% 09/13/28 P/P | 0.09% |
51 | n/a | Evozyne Inc Ser B Pc Pp | 0.08% |
52 | MTSR | Metsera, Inc. | 0.03% |
53 | n/a | Paragon Bio Ser D-2 Pc Pp | 0.02% |
54 | n/a | Paragon Bio Inc Ser D-1 Pc Pp | 0.02% |
55 | n/a | Evozyne Inc Ser A Pc Pp | 0.01% |
56 | n/a | Castle Creek Bi Sr C Pc Prp Pp | 0.00% |
57 | n/a | Castle Creek Bios Sr D-2 Pc Pp | 0.00% |
58 | n/a | LEAP THERAPEUTICS INC WT | 0.00% |
59 | n/a | Medavail Holdings Inc Pipe | 0.00% |
60 | n/a | Eur Spot Cc | -0.00% |
As of Mar 31, 2025